企業プロフィール
DURECT Corporation 株価・ニュース・カタリスト
- ティッカー:
- DRRX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for DRRX.
企業概要
事業概要
DURECT was a specialty pharmaceutical company focused on pain, liver disease, and drug-delivery programs before its restructuring and public-market decline. Its story centered on trying to commercialize niche assets.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ before restructuring, DURECT sat in specialty biopharma.
ビジネスモデルの特徴
The business depended on product development, delivery technology, and the chance to create value from a narrow portfolio.
バイオ業界での位置付け
DURECT belongs to the historical specialty-pharma set rather than the current live public-company universe.
今後のカタリスト
- DURECT’s catalysts are legacy and transaction-related, with any remaining asset-resolution or capital-update milestone doing the work. The company is no longer a live pipeline name.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。